Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 9,168 shares of the firm’s stock in a transaction dated Wednesday, July 3rd. The shares were sold at an average price of $7.23, for a total transaction of $66,284.64. Following the transaction, the chief executive officer now owns 296,070 shares of the company’s stock, valued at approximately $2,140,586.10. The transaction was disclosed in a document filed with the SEC, which is available at this link.
K Charles Janac also recently made the following trade(s):
- On Monday, July 1st, K Charles Janac sold 4,583 shares of Arteris stock. The shares were sold at an average price of $7.24, for a total transaction of $33,180.92.
- On Tuesday, June 4th, K Charles Janac sold 3,303 shares of Arteris stock. The stock was sold at an average price of $7.70, for a total transaction of $25,433.10.
Arteris Price Performance
Arteris stock remained flat at $7.21 during midday trading on Wednesday. 111,247 shares of the company were exchanged, compared to its average volume of 192,153. Arteris, Inc. has a 1 year low of $4.20 and a 1 year high of $9.54. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.24 and a current ratio of 1.24. The firm has a market cap of $277.43 million, a price-to-earnings ratio of -7.00 and a beta of 1.11. The firm has a fifty day moving average of $7.81 and a two-hundred day moving average of $6.95.
Hedge Funds Weigh In On Arteris
Institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in shares of Arteris by 0.3% in the first quarter. Vanguard Group Inc. now owns 1,146,224 shares of the company’s stock worth $8,390,000 after purchasing an additional 3,242 shares in the last quarter. Worth Venture Partners LLC increased its stake in Arteris by 22.6% in the 3rd quarter. Worth Venture Partners LLC now owns 51,301 shares of the company’s stock valued at $334,000 after buying an additional 9,448 shares during the period. Federated Hermes Inc. lifted its position in Arteris by 8.3% in the 3rd quarter. Federated Hermes Inc. now owns 130,000 shares of the company’s stock worth $846,000 after buying an additional 10,000 shares in the last quarter. Victory Capital Management Inc. acquired a new stake in shares of Arteris during the 4th quarter valued at $60,000. Finally, Algert Global LLC purchased a new position in shares of Arteris during the 3rd quarter valued at $142,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.
Analysts Set New Price Targets
AIP has been the subject of a number of recent research reports. Jefferies Financial Group reiterated a “hold” rating and set a $9.00 price objective (down previously from $11.00) on shares of Arteris in a research report on Monday, May 13th. Rosenblatt Securities reaffirmed a “buy” rating and set a $15.00 target price on shares of Arteris in a report on Friday, May 3rd. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, Arteris currently has an average rating of “Moderate Buy” and a consensus target price of $13.40.
Check Out Our Latest Research Report on Arteris
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading
- Five stocks we like better than Arteris
- 10 Best Airline Stocks to Buy
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Trading Stocks: RSI and Why it’s Useful
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- How to Use Stock Screeners to Find Stocks
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.